Replies to post #187664 on Anavex Life Sciences Corp (AVXL)

[jimmy667]

Based on my non-professional and cursory knowledge and understanding of the claimed MOA of A2-73 addressing misfolded proteins which as I understand it are expressions of genes not based on DNA (epigenetic) and if the true experts are right that RETT is epigenetic, misfolded proteins during gene expression then it would seem that Anavex is at least targeting the right pathway for treating RETT as well as other epigenetic disorders like Epilepsy.
No wonder Dr Kaufmann is now Anavex CMO and no wonder the preeminent Epilepsy researcher Dr Andrew Cole is on Anavex Board of Scientific Advisors. (He is on the SAB of only one other Company- Sage, also of the ERP Consortium)